openPR Logo
Press release

Portal Hypertension Market Professional Survey by Booming Types & Application Report 2025

05-30-2018 01:30 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: TMR Research

/ PR Agency: TMR Research
Portal Hypertension Market Professional Survey by Booming

Global Portal Hypertension Market: Snapshot

At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. The generic drugs hold a sway over the market and the scope of treatment under them include beta blockers, vasopressin and its analogues, and somatostatin and its analogues. In the near future, the portal hypertension market is primed to grow at a healthy clip due to the spike in liver cirrhosis, which may cause portal hypertension and other hepatic disorders.

Request Sample Copy of the Report @
https://www.tmrresearch.com/sample/sample?flag=B&rep_id=56

Portal hypertension results in increase of blood pressure within the portal venous system. It may cause veins in stomach, esophagus, umbilical area, or rectum to swell. In extreme cases, these swollen vein can rupture and bleed, thereby causing life-threatening complications.

Some of the noteworthy candidates under phase III of clinical trials are Udenafil (DA-8519), Sapropterin (tetrahydrobiopterin), and Octreolin (octreotide). When approved and launched, these drugs would have the potential to rake in substantial revenue in the market.

As far as diagnosis is concerned, Duplex Doppler ultrasonography has been seeing robust demand on being the current available imaging technique applied for diagnosing portal hypertension. Besides this, methods such as angioplasty, computed tomography (CT) scanning, bleeding scan, and magnetic resonance imaging (MRI) are also considered aviable methods for precise diagnosis.

Noteworthy names operating in the global portal hypertension market are Ono Pharmaceutical Co., Ltd., Dong-A Socio Holdings Co Ltd., Novartis AG, United Therapeutics Corporation, Genextra S.p.a., Aptalis Pharma Inc., Gilead Sciences, Inc., Debiovision, Inc., Chiasma, Inc., Govind Ballabh Pant Hospital, and Dr. Falk Pharma GmbH.

Request TOC of the Report @
https://www.tmrresearch.com/sample/sample?flag=T&rep_id=56

Global Portal Hypertension Market: Overview

Portal hypertension is a clinical condition in which blood pressure within the portal venous system increases. The condition may lead to the development of swollen veins within stomach, esophagus, umbilical area, or rectum. In severe cases, these swollen vein can rupture and bleed, thereby leading to potentially life-threatening complications. As per reports, liver cirrhosis is the most common cause of portal hypertension. Hence a rising incidence of liver cirrhosis is often related to the increasing demand for effective treatment for portal hypertension.

In this report, TMR Research not only evaluates opportunities prevalent for the available treatment and diagnosis techniques for portal hypertension but also presents a detailed assessment of therapeutic pipeline. The potential market trajectory post approval of novel therapeutics is determined based on exhaustive information obtained from proven industrial sources. The report thus compiles data aimed at providing a comprehensive overview of the global portal hypertension market to the readers.

Global Portal Hypertension Market: Available Treatment Options

Duplex Doppler ultrasonography has been witnessing significantly high demand on being the current available imaging technique applied for diagnosing portal hypertension. Besides this, methods such as a computed tomography (CT) scanning, bleeding scan, angioplasty, and magnetic resonance imaging (MRI) are also considered viable methods for precise diagnosis. As these constitute key segments in the global hypertension market, the report presents an in-depth analysis of the factors influencing the market’s trajectory across aforementioned segments.

Read Comprehensive Overview of Report @
https://www.tmrresearch.com/portal-hypertension-market

The currently available treatment for portal hypertension includes medications comprising beta blockers such as Propranolol and Nadolol and endoscopic therapies such as sclerotherapy and banding. Vasoactive agents are also preferred in the treatment of portal hypertension due to its ability of reducing the in-variceal bleeding and ultimately helping to lower the blood pressure. In acute conditions vasoconstrictors such as octreotide and somastostatin are administered, which explains their high demand in the global portal hypertension market.

Global Portal Hypertension Market: Therapeutics and Pipeline Analysis

The global market for portal hypertension currently has a limited number of treatment options and there is absence of a specialized drugs approved to be administered for the treatment of portal hypertension. However, the generic drugs segment currently holds dominance in the market, the scope of treatment under which includes vasopressin and its analogues, beta blockers, and somatostatin and its analogues. This also demonstrates lucrative prospects for therapeutic research and development. As per TMR, the portal hypertension market is poised to exhibit exponential growth on account of the increasing incidence of liver cirrhosis, which may lead to portal hypertension and other hepatic disorders.

The pipeline analysis of the market consists of products currently under the phase III of clinical trials. Some of the most notable candidates are Sapropterin (tetrahydrobiopterin), Octreolin (octreotide), and Udenafil (DA-8519). Once approved, the launch of these drugs could generate high revenue for the market.

Global Portal Hypertension Market: Vendor Landscape

To study the competition prevailing in the global portal hypertension market, the report profiles a few of the companies operating therein. It conducts SWOT analysis to evaluate the strengths and weaknesses of the companies profiled and identify threats and opportunities that these enterprises could face over the course of the forecast period. Some of the prominent players in the global portal hypertension market are Ono Pharmaceutical Co., Ltd., United Therapeutics Corporation, Chiasma, Inc., Genextra S.p.a., Aptalis Pharma Inc., Gilead Sciences, Inc., Debiovision, Inc., Dong-A Socio Holdings Co Ltd., Govind Ballabh Pant Hospital, Dr. Falk Pharma GmbH, and Novartis AG.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Portal Hypertension Market Professional Survey by Booming Types & Application Report 2025 here

News-ID: 1066068 • Views: 1435

More Releases from TMR Research

Remote Patient Monitoring (RPM) Market to Witness Widespread Expansion During 20 …
Global Remote Patient Monitoring (RPM) Market: Overview A rising need for expansion of healthcare access together with growth of the geriatric population unable to travel down to healthcare facilities is likely to play an important role in the development of the global remote patient monitoring (RPM) market over the timeframe of analysis, from 2019 to 2029. In addition to that, cost benefits of medical resources together with rising incidences of various
Digital Therapeutics Market to Record Ascending Growth by 2029
Global Digital Therapeutics Market: Overview Digital therapeutics (DTx) is tasked with the delivery of therapeutic interventions that are based on evidence. These deliveries is made to patients and are driven by advanced software programs so as to treat, manage, and avert a wide range of behavioral, metal, and physical conditions of a patient. Digital therapeutics comprises an independent group of proof-based products within the set up of a broader digital health
Bone Conduction Hearing Devices Market to Discern Steadfast Expansion During 202 …
Bone Conduction Hearing Devices Market: Overview The recent developments in medical sector such as invisible devices, and minimally invasive surgeries are the key factors promoting the growth of the global bone conduction hearing devices market. These devices function by absorbing the air waves present in the outer ear and changes it to electrical waves and sends it to the inner ear. The brain then absorbs the vibrations received from the inner
Nasal Oxygen Cannula Market to Register Steady Growth During 2029
Global Nasal Oxygen Cannula Market: Overview The demand within the global nasal oxygen cannula market is growing at a sound pace in recent times. The rising incidence of respiratory disorders has created new opportunities for growth within the global nasal oxygen cannula market. The healthcare industry is leveraging new-age technologies to improve the quality of life for patients with chronic ailments. In addition to this, the heavy investments made towards improving

All 5 Releases


More Releases for Portal

Patient Portal Software Market
Patient Portal Software Market The study on the global Patient Portal Software Market which is backed by extensive primary and detailed secondary research, involving numerous static databases, national government documentation, latest news articles, press releases, company annual reports, financial reports, pertinent patent and administrative databases, as well as a range of internal and external proprietary databases. Request for a free sample report @ https://www.reportsmonitor.com/request_sample/105448 Giving a fleeting introduction to the prerequisites of the industry, the report starts
International Property Portal Launches
For Immediate Release: January 12, 2017 Contact: info@qlistings.com QUALITY LISTINGS, AN INTERNATIONAL REAL ESTATE PORTAL, OFFICIALLY LAUNCHES Quality Listings, a new international comprehensive real estate portal committed to delivering both buyers and sellers with a high level of expertise, customer service, and attention to detail in the marketing of real estate worldwide, this week officially launched their platform for everyone intent on garnering widespread real estate traction in 2017. Inspired
Arbor Reporting Portal
Arbor Financial Systems have just released a new feature, Arbor Reporting Portal (ARP). This portal can be used on all devices with browser access, and can be distributed to whomever, whenever and wherever. ARP allows traders and fund managers to create a wide range of reports, from simple grids to complex diagrams and analysis. This is the latest addition to Arbor’s array of technologies, having just published Arbor Mobile Reporting.
European Data Portal launched
Luxembourg – The European Commission has launched a quality-assured beta version of the European Data Portal, with more than 240,000 datasets, at the European Data Forum. An international consortium, which is led by Capgemini and of which con terra is a member, is responsible for the implementation. The European Data Portal (www.europeandataportal.eu) enables fast and simple searching of open data from 34 European countries and supports their systematic onward use.
Minglebox.com Launches WAP Portal
A unique mobile offering that helps Indian students take tests, search courses and educational institutes Bangalore, Feb 14 2011: Identifying the need for a mobile based education solution for Indian students, Minglebox.com – India’s No. 1 education network has launched Minglebox On Mobile, a WAP portal that enables students to access key features of the website right at their fingertips over their mobile phones. Being the first of its kind mobile
Luxor city portal - first official city portal in Egypt
(31 March, 2009) – Tourists anywhere in the world who wish to find out more about Luxor before their visit to this city of wonders can now avail of a wide range of online services and information with the launch of the Luxor portal, developed and designed by LINK Development in association with Microsoft Egypt. The first official city portal in Egypt (luxoregypt.org) which was inaugurated during an official visit by